INTERLAB (Munich, Germany), the German central laboratory with global operations, increases its European project and data management team by 30% to absorb additional business generated recently.
INTERLAB (Munich, Germany), the German central laboratory with global operations,
increases its European project and data management team by 30% to address the expected
additional business generated by two US competitors pulling out of the European market and
a third laboratory closing down its German lab facilities. These recent developments will
allow INTERLAB to grow above the expected rate of 35% in 2009. INTERLAB is providing
global central lab services since 1994. Since 2006 China and India are covered as the most
recent regions. Additional services provided by INTERLAB include visit-kit building,
extended storage of frozen samples and rental/purchase of centrifuges and freezers.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.